Crispr Gene Editing Shows Promise in Blood Disease Update

(Bloomberg) -- Longer-term results from a first-in-human study of the gene-editing tool Crispr showcased the technology’s potential and delivered a win for the company that shares the platform’s na...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.